The use of multiplex platforms for absolute and relative protein quantification of clinical material

EuPA Open Proteomics

Volumn 3, Issue , 2014, Pages 37-47

  Christiansson, Lisa ^a   Mustjoki, Satu ^b   Simonsson, Bengt ^a   Olsson Strömberg, Ulla ^a,c   Loskog, Angelica S I ^a   Mangsbo, Sara M ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chronic myeloid leukemia; ELISA; Luminex; Meso Scale Discovery; Multiplex protein quantification; Somalogic

Indexed keywords

CD40 LIGAND; DASATINIB; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; IMATINIB; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BB; SPYRCEL; STROMELYSIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANALYTIC METHOD; ANALYTICAL EQUIPMENT; ARTICLE; BIOPLEX TEST; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CHRONIC MYELOID LEUKEMIA; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MEASUREMENT ACCURACY; MESO SCALE DISCOVERY; MYRIAD RBM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; QUANTITATIVE ANALYSIS; SOMALOGIC; TREATMENT RESPONSE;

EID: 84902478661     PISSN: None     EISSN: 22129685     Source Type: Journal    
DOI: 10.1016/j.euprot.2014.02.002     Document Type: Article

References (21)

1. Kingsmore S.F. Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat Rev Drug Discov 2006, 5:310-320.
2. Ellington A.A., Kullo I.J., Bailey K.R., Klee G.G. Antibody-based protein multiplex platforms: technical and operational challenges. Clin Chem 2010, 56:186-193.
3. Vignali D.A. Multiplexed particle-based flow cytometric assays. J Immunol Methods 2000, 243:243-255.
4. Lai Y., Feldman K.L., Clark R.S. Enzyme-linked immunosorbent assays (ELISAs). Crit Care Med 2005, 33:S433-S434.
5. Miao W. Electrogenerated chemiluminescence and its biorelated applications. Chem Rev 2008, 108:2506-2553.
6. Fulton R.J., McDade R.L., Smith P.L., Kienker L.J., Kettman J.R. Advanced multiplexed analysis with the FlowMetrix system. Clin Chem 1997, 43:1749-1756.
7. Raz S.R., Haasnoot W. Multiplex bioanalytical methods for food and environmental monitoring. Trac-Trend Anal Chem 2011, 30:1526-1537.
8. 1 February 2013. http://www.mesoscale.com/.
9. 1 February 2013. http://www.luminexcorp.com/.
10. 1 February 2013. http://www.somalogic.com/.
11. Gold L., Ayers D., Bertino J., Bock C., Bock A., Brody E.N., et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS ONE 2010, 5:e15004.
12. Chowdhury F., Williams A., Johnson P. Validation and comparison of two multiplex technologies, Luminex and Mesoscale Discovery, for human cytokine profiling. J Immunol Methods 2009, 340:55-64.
13. Richens J.L., Urbanowicz R.A., Metcalf R., Corne J., O'Shea P., Fairclough L. Quantitative validation and comparison of multiplex cytokine kits. J Biomol Screen 2010, 15:562-568.
14. Breen E.C., Reynolds S.M., Cox C., Jacobson L.P., Magpantay L., Mulder C.B., et al. Multisite comparison of high-sensitivity multiplex cytokine assays. Clin Vaccine Immunol 2011, 18:1229-1242.
15. Mukherjee S., Katki K., Arisi G.M., Foresti M.L., Shapiro L.A. Early TBI-induced cytokine alterations are similarly detected by two distinct methods of multiplex assay. Front Mol Neurosci 2011, 4:21.
16. Fu Q., Zhu J., Van Eyk J.E. Comparison of multiplex immunoassay platforms. Clin Chem 2010, 56:314-318.
17. Nechansky A., Grunt S., Roitt I.M., Kircheis R. Comparison of the calibration standards of three commercially available multiplex kits for human cytokine measurement to WHO standards reveals striking differences. Biomark Insights 2008, 3:227-235.
18. Han K., Liang Z., Zhou N. Design strategies for aptamer-based biosensors. Sensors (Basel) 2010, 10:4541-4557.
19. Kelley M., DeSilva B. Key elements of bioanalytical method validation for macromolecules. Aaps J 2007, 9:E156-E163.
20. Schipke C.G., Prokop S., Heppner F.L., Heuser I., Peters O. Comparison of immunosorbent assays for the quantification of biomarkers for Alzheimer's disease in human cerebrospinal fluid. Dement Geriatr Cogn Disord 2011, 31:139-145.
21. Valentin M.A., Ma S., Zhao A., Legay F., Avrameas A. Validation of immunoassay for protein biomarkers: bioanalytical study plan implementation to support pre-clinical and clinical studies. J Pharm Biomed Anal 2011, 55:869-877.